Search research articles
Contact Us
Filters
Showing results (71-80 of 138) with videos related to
Page
of 14
Sort By:
European Journal of Cancer & Clinical Oncology
|
June 1, 1987
The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin
S E Dible, Z H Siddik, F E Boxall, et al.
Biochemical Pharmacology
|
November 1, 1986
The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the rat
D R Newell, P M O'Connor, A H Calvert, et al.
British Journal of Clinical Pharmacology
|
December 1, 1983
The clinical pharmacology of chlorambucil and prednimustine
D R Newell, A H Calvert, K R Harrap, et al.
British Journal of Cancer
|
January 1, 1983
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies
J R Muindi, D R Newell, I E Smith, et al.
Journal of the National Cancer Institute
|
January 1, 1977
Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues
J A Straw, D C Talbot, G A Taylor, et al.
Annals of the New York Academy of Sciences
|
November 30, 1971
Sites of action of amethopterin: intrinsic and acquired drug resistance
K R Harrap, B T Hill, M E Furness, et al.
Neoplasma
|
January 1, 1992
The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin
M C Nicolson, R M Orr, C F O'Neill, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1984
Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics
A L Jackman, A H Calvert, L I Hart, et al.
Journal of Medicinal Chemistry
|
August 1, 1984
A reappraisal of the effect upon thymidine kinase of thymidine derivatives carrying large groups at the 5'-position
S E Barrie, L C Davies, J A Stock, et al.
Biochemical Pharmacology
|
October 15, 1984
Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717
A L Jackman, G A Taylor, A H Calvert, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 138) with videos related to
Sort By:
Page
of 14
European Journal of Cancer & Clinical Oncology
|
June 1, 1987
The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin
S E Dible, Z H Siddik, F E Boxall, et al.
Biochemical Pharmacology
|
November 1, 1986
The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the rat
D R Newell, P M O'Connor, A H Calvert, et al.
British Journal of Clinical Pharmacology
|
December 1, 1983
The clinical pharmacology of chlorambucil and prednimustine
D R Newell, A H Calvert, K R Harrap, et al.
British Journal of Cancer
|
January 1, 1983
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies
J R Muindi, D R Newell, I E Smith, et al.
Journal of the National Cancer Institute
|
January 1, 1977
Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues
J A Straw, D C Talbot, G A Taylor, et al.
Annals of the New York Academy of Sciences
|
November 30, 1971
Sites of action of amethopterin: intrinsic and acquired drug resistance
K R Harrap, B T Hill, M E Furness, et al.
Neoplasma
|
January 1, 1992
The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin
M C Nicolson, R M Orr, C F O'Neill, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1984
Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics
A L Jackman, A H Calvert, L I Hart, et al.
Journal of Medicinal Chemistry
|
August 1, 1984
A reappraisal of the effect upon thymidine kinase of thymidine derivatives carrying large groups at the 5'-position
S E Barrie, L C Davies, J A Stock, et al.
Biochemical Pharmacology
|
October 15, 1984
Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717
A L Jackman, G A Taylor, A H Calvert, et al.
Page
of 14